Wealth Management Partners LLC Grows Position in Astera Labs, Inc. $ALAB

Wealth Management Partners LLC raised its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 28.8% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 42,181 shares of the company’s stock after acquiring an additional 9,426 shares during the quarter. Astera Labs accounts for about 1.3% of Wealth Management Partners LLC’s holdings, making the stock its 15th biggest position. Wealth Management Partners LLC’s holdings in Astera Labs were worth $4,621,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. Buffalo Business & Estate Services Ltd. purchased a new position in shares of Astera Labs in the 1st quarter valued at about $292,000. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in shares of Astera Labs in the first quarter valued at about $1,065,000. Diversified Trust Co boosted its holdings in Astera Labs by 62.8% during the first quarter. Diversified Trust Co now owns 4,369 shares of the company’s stock worth $479,000 after buying an additional 1,685 shares in the last quarter. Hsbc Holdings PLC boosted its holdings in Astera Labs by 128.5% during the fourth quarter. Hsbc Holdings PLC now owns 83,721 shares of the company’s stock worth $14,126,000 after buying an additional 47,081 shares in the last quarter. Finally, Spear Advisors LLC acquired a new position in Astera Labs during the fourth quarter worth about $15,787,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the sale, the director owned 319,863 shares of the company’s stock, valued at approximately $34,420,457.43. This represents a 36.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the sale, the chief executive officer owned 4,079,322 shares in the company, valued at approximately $702,214,489.08. This trade represents a 7.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,161,256 shares of company stock valued at $459,844,296 in the last ninety days. Corporate insiders own 10.40% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Royal Bank Of Canada increased their target price on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, May 6th. Rothschild & Co Redburn began coverage on Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price target on the stock. Bank of America upped their price target on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday. Morgan Stanley raised their price objective on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Finally, Needham & Company LLC lifted their price objective on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $244.75.

Astera Labs Trading Down 9.7%

NASDAQ:ALAB opened at $397.02 on Wednesday. The firm has a 50-day moving average price of $275.59 and a two-hundred day moving average price of $191.30. Astera Labs, Inc. has a twelve month low of $84.78 and a twelve month high of $440.99. The company has a market capitalization of $68.05 billion, a P/E ratio of 268.26, a price-to-earnings-growth ratio of 5.82 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the previous year, the business posted $0.33 earnings per share. The firm’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.